Centene Corporation with ticker code (CNC) have now 15 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $110.00 and $72.00 and has a mean target at $83.53. Given that the stocks previous close was at $73.23 and the analysts are correct then there would likely be a percentage uptick in value of 14.1%. The 50 day MA is $69.71 and the 200 day moving average is $67.58. The market capitalization for the company is 39.12B. The stock price is currently at: $73.23 USD
The potential market cap would be $44,621,810,664 based on the market consensus.
The company has a dividend yield of 1.57%. Other points of data to note are a P/E ratio of 16.24, revenue per share of $253.50 and a 3.85% return on assets.
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.
